share_log

424B5: Prospectus

SEC announcement ·  Jul 27 01:23
Summary by Futu AI
60 Degrees Pharmaceuticals, Inc., listed on The Nasdaq Capital Market under the symbol 'SXTP', has announced an increase in the maximum aggregate gross sales price of its common stock to $2,190,416 through an At the Market Issuance Sales Agreement with WallachBeth Capital LLC. This increase, detailed in a prospectus supplement filed on July 26, 2024, amends previous registrations to allow for additional sales under the agreement. As of the filing date, 60 Degrees Pharmaceuticals has sold 7,525,879 shares for an aggregate gross sales price of $1,890,500.81. The company's outstanding common stock held by non-affiliates is valued at approximately $6,571,249, based on a share price of $0.351 as of June 7, 2024. The company adheres to the SEC's General Instruction I.B.6 of Form S-3, limiting sales to no more than one-third of their public float in a 12-month period, provided the public float remains below $75 million. Investors are advised to consider the risk factors outlined in the accompanying prospectus supplement and base prospectus, as well as other SEC filings.
60 Degrees Pharmaceuticals, Inc., listed on The Nasdaq Capital Market under the symbol 'SXTP', has announced an increase in the maximum aggregate gross sales price of its common stock to $2,190,416 through an At the Market Issuance Sales Agreement with WallachBeth Capital LLC. This increase, detailed in a prospectus supplement filed on July 26, 2024, amends previous registrations to allow for additional sales under the agreement. As of the filing date, 60 Degrees Pharmaceuticals has sold 7,525,879 shares for an aggregate gross sales price of $1,890,500.81. The company's outstanding common stock held by non-affiliates is valued at approximately $6,571,249, based on a share price of $0.351 as of June 7, 2024. The company adheres to the SEC's General Instruction I.B.6 of Form S-3, limiting sales to no more than one-third of their public float in a 12-month period, provided the public float remains below $75 million. Investors are advised to consider the risk factors outlined in the accompanying prospectus supplement and base prospectus, as well as other SEC filings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.